Herein, in this study, we demonstrated that silencing PinX1 destroyed the function of telomerase in telomere maintainance in vitro and in vivo, thus effectively promoting the immune-activating effects of IR and significantly enhancing the antitumor efficacy of radioimmunotherapy in NSCLC cells. The gene discussed is PINX1; the disease is non-small cell lung carcinoma.